Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
  • Subscribe to newsletter
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://www.linkedin.com/company/coalition-for-global-hepatitis-elimination
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
    • CGHE Annual Reports
      • Annual Report 2022
      • Annual Report 2021
      • Annual Report 2020
    • CGHE Publications
    • Partner programs
      • Programs search
  • Data dashboards
    • Country data dashboards
    • National Hepatitis Elimination Profiles
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • HCV Treatment in Pregnancy
      • Tip-HepC Registry
      • TiP-HepC Systematic Review Results
      • Scientific Advisory Committee: TipHepC
    • Action Plan Systematic Review
    • Hepatitis B Birth Dose Vaccine Systematic Review
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing Systematic Review
    • COVID-19 Evidence Hub
      • COVID-19 and Liver Disease Synthesis
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
    • Innovations in Hepatitis Elimination (CLD Series)
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
    • Hepatitis Elimination Help Desk
  • Resources
    • Partnering with Civil Society Organizations in Africa to Increase Hepatitis B Birth Dose Vaccination
    • Report: Sharing Investments in Pandemic Preparedness and Hepatitis Elimination
    • Expanding access to hepatitis C prevention, testing, and treatment in prisons
    • Hep C Elimination Tool
      • Access the Tool
      • User Guide
      • Frequently Asked Questions
    • Technical Assistance Help Desk and Frequently Asked Questions
    • Toolkit: Birth Dose Vaccination in Africa
    • Search resources
  • Elimination champions
    • Nominations for 2023 Elimination Champions
  • News
    • Announcements
    • US Hepatitis C Elimination Initiative
    • News search
    • HepEquity Blog
      • HepEquity Blog: Caroline Thomas: A Catalyst for Change in Indonesia
      • HepEquity Blog: Highlights from the CGHE Staff Bibliography
      • HepEquity Blog: Champions Don’t Wait: Dr. Charles Adjei’s Hepatitis Elimination Efforts in Ghana
      • HepEquity Blog: Local Hepatitis Elimination and Prevention Program (LHEAP) Launches in Rawalpindi, Pakistan
    • Elimination Champions
    • Events
    • Newsletters
    • Press releases
    • Publications
  • Webinars & Events
    • HDV Webinar Series
      • HDV Webinar Series
    • HCV in Prisons
    • Treatment of HCV in Pregnancy for Hepatitis (TiP-HepC)
      • Webinar 1: Challenges
      • Webinar 2: Strategies
      • Webinar 3: Recommendations
    • NIH "Moving from Hepatitis Discovery to Elimination"
    • Hep Test
    • Linkage to care
    • Strategic Information Collaborative
    • Regional Hepatitis Elimination
    • HepB Birth Dose Introduction in AFRO
    • Innovations in Hepatitis Elimination
    • Search webinars
  • UN Group of Friends
  1. Home
  2. Evidence base
  3. Evidence base search

Evidence base articles search

The evidence base was developed using rigorous review methods for the identification and quality assessment of eligible systematic reviews and guideline and policy documents. In response to identified global research priorities, the evidence base currently presents characteristics of interventions to inform implementation of hepatitis B birth dose , HCV testing and hepatitis B and C action plans. Updates to the evidence base are planned to address subsequent priorities.

Edit

Evidence base search

Filter

  • HCV testing
  • (-) Hepatitis C
  • HCV testing and linkage to Care
  • Linkage to care
  • Screening and diagnosis
  • (-) Testing
  • (-) General Population
  • (-) China
  • Retrospective cohort
  • Laboratory-based antibody test
  • Laboratory-based antibody test,Laboratory-based PCR/RNA (confirmatory) test
  • (-) Laboratory-based PCR/RNA (confirmatory) test
Displaying 1 - 1 of 1
  • A hiddenly high hepatitis C virus related liver disease burden among Chinese patients with non-liver disease complaints: A hospital based study from 2013 to 2017

    2018
    Asian Pacific Journal of Tropical Medicine

    11

    171-176

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://www.linkedin.com/company/coalition-for-global-hepatitis-elimination

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2023 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media
q